Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -0.064\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] O=[N+]([O-])c1ccc(Cl)c(S(=O)(=O)/N=C(/c2ccccc2)N2CCOCC2)c1
[b] CCC(CO)Oc1cc(NCc2ccccc2F)c2ncn(C(C)C)c2c1
[c] O=C(N/C(=C\c1ccccc1)C(=O)N1CCCCC1)c1ccc(Br)o1
Answer: b. CCC(CO)Oc1cc(NCc2ccccc2F)c2ncn(C(C)C)c2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(CO)Oc1cc(NCc2ccccc2F)c2ncn(C(C)C)c2c1
CCC(CO)Oc1cc(NCc2ccccc2F)c2ncn(C(C)C)c2c1
2-[7-[(2-fluorophenyl)methylamino]-3-propan-2-ylbenzimidazol-5-yl]oxybutan-1-ol